Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Explore more Johnson & Johnson sites:

Code of Business Conduct

    • At Johnson & Johnson, we believe acting ethically and responsibly is not only the right thing to do, but also the right thing to do for our business. Our Johnson & Johnson Code of Business Conduct ensures that we hold ourselves and how we do business to a high standard, allowing us to fulfill our obligations to the many stakeholders we serve.

      Effective March 30, 2020, Johnson & Johnson amended its Code of Business Conduct to provide enhanced guidance on addressing the evolving business environment. Effective January 2, 2023, the title of our Chairman and CEO, Joaquin Duato was updated. No other content changes were made.

    • Our Credo Integrity Line

      Our Credo Integrity Line is an integral component of our strong culture of integrity at Johnson & Johnson. It provides a channel for anyone (including employees, business partners, customers, consumers and others) to report potential violations of the Code of Business Conduct, other company policies or applicable laws and regulations in our countries of operation. Our Credo Integrity Line is available 24 hours a day, 7 days a week and in 24 languages. Concerns can be filed digitally at or by calling a toll-free number (international dialing instructions on the same website).

    • Additional Policies and Resources

      The values and principles spelled out in Our Credo serve as our compass; the Johnson & Johnson Code of Business Conduct is the road map that helps us stay on course with those values. The Codes sets requirements for business conduct and serves as a foundation for our Company policies, procedures and guidelines, all of which provide additional guidance on expected behaviors.

More From Johnson & Johnson

Back to top
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.